Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.


Implementation Research Takes On an Increasingly Essential Role in Oncology

August 29th 2022

The publication of the objectively meaningful outcomes in high-impact peer-reviewed medical journals does not necessarily result in the observations being implemented into routine clinical care.

Is War a Good Metaphor for Cancer Care?

August 10th 2022

The National Cancer Act of 1971 introduced the concept of a “war on cancer,” which has since affected the language we use when discussing the disease.

Errors in Primary Payer Data Persist in Cancer Registries

August 10th 2022

Primary payer data reported by cancer registries are subject to measurement error and can result in biased estimates of insurance-related policy effects.

Machine Learning Develops Into a Powerful Tool in Cancer Care

July 8th 2022

The expansion of technology includes machine learning, which is quickly emerging as a dynamic aid for clinicians in every aspect of cancer care, from diagnosis to treatment decisions.

Real-World Patient Engagement Highlights Opportunities for Digital Care Integration

July 7th 2022

Digital health solutions have the potential to improve outcomes via remote symptom monitoring, increase patient/physician communication, and improve patient education.

Metrics in Clinical Medicine and Clinical Trials Should Look Beyond the P Value

June 30th 2022

From evaluating clinical outcomes to determining payment for services, measurements are important in health care.

Innovations in Patient-Reported Outcomes Lead to Better Care

May 20th 2022

For decades in cancer care, the compiling of patient-reported outcomes was limited to simple standardized questionnaires completed with pen and paper.

New Programs Unlock Patient Access to Oncology Care

May 19th 2022

Developing a system with a patient-centric focus, investigators at Yale Cancer Center and Moffitt Cancer Center initiated pilot programs to offer patients better access to care following a diagnosis of cancer.

Data-Driven Health Economics Research Can Improve Clinical, Economic Outcomes

May 6th 2022

Data-driven health economics and outcomes research offers clinicians effective methods for improving quality of life and outcomes for patients and optimizing economic benefits for the practice.

We Must Improve Communication With the Public

May 2nd 2022

Maurie Markman, MD, discusses the need for oncologists to improve communication with the public and patients.

Building the Community Oncology Practice of the Future Demands a Comprehensive Approach

April 29th 2022

As cancer care continues to shift away from a fee-for-service model to a value-based care model, clinicians and institutions will need to be adaptable and innovative to build effective community oncology practices of the future.

Pragmatic Clinical Trials Can Play a Key Role in Oncology

April 20th 2022

Pragmatic clinical trials “inform a clinical or policy decision by providing evidence for adoption of the intervention into real-world clinical practice.”

Advances in Learning Health Care Systems Strive to Optimize Cancer Care

April 19th 2022

As technology and cancer care continue to become intertwined at every level, there is an imperative need to effectively process and use vast amounts of data to provide the highest level of care for patients.

Dr. Shereck Highlights a Day In the Life of an Attending Physician

March 21st 2022

Evan B. Shereck, MD, MEd, serves as professor of pediatrics, Division of Hematology and Oncology, School of Medicine; program director, Pediatric Hematology/Oncology Fellowship; associate director, Cancer Research Training, Knight Cancer Institute; and block co-director, Blood and Host Defense at Oregon Health & Science University. In this episode, she highlights the average work day as an attending physician.

Dr. Shereck Shares How She Makes Medical Education More Fun and Accessible

March 21st 2022

Evan B. Shereck, MD, MEd, serves as professor of pediatrics, Division of Hematology and Oncology, School of Medicine; program director, Pediatric Hematology/Oncology Fellowship; associate director, Cancer Research Training, Knight Cancer Institute; and block co-director, Blood and Host Defense at Oregon Health & Science University. In this episode, she expands on her process for making medical education more accessible.

Dr. Shereck Highlights Her Path to Becoming a Fellowship Director

March 21st 2022

Evan B. Shereck, MD, MEd, serves as professor of pediatrics, Division of Hematology and Oncology, School of Medicine; program director, Pediatric Hematology/Oncology Fellowship; associate director, Cancer Research Training, Knight Cancer Institute; and block co-director, Blood and Host Defense at Oregon Health & Science University. In this episode, she highlights her path toward becoming a fellowship director.

Dr. Shereck Shares How She Found Her Place in Pediatric Oncology

March 21st 2022

Evan B. Shereck, MD, MEd, professor of pediatrics, Division of Hematology and Oncology, School of Medicine; program director, Pediatric Hematology/Oncology Fellowship; associate director, Cancer Research Training, Knight Cancer Institute; and block co-director, Blood and Host Defense at Oregon Health & Science University, discusses how she works to "gamify" medical education.

Dr. Shereck Discusses Falling in Love With Pediatric Oncology

March 21st 2022

Evan B. Shereck, MD, MEd, serves as professor of pediatrics, Division of Hematology and Oncology, School of Medicine; program director, Pediatric Hematology/Oncology Fellowship; associate director, Cancer Research Training, Knight Cancer Institute; and block co-director, Blood and Host Defense at Oregon Health & Science University. In this episode, she discussed her passion with pediatric oncology.

Cancer Efforts Face Setback as Ongoing Challenges to Scientific Authority Continue

March 3rd 2022

Maurie Markman, MD, discusses the obstacles presented to cancer efforts as a result of challenges to scientific authority during the COVID-19 pandemic.

FDA Issues New Clinical Trial Guidelines to Further Cancer Therapy Development

March 1st 2022

New FDA guidelines reflect improvements in medical science over the past 6 years and are designed to facilitate continued advancement in cancer prevention, detection, research, and patient care.

x